** Shares of drugmaker Ionis Pharmaceuticals IONS.O rise 6% to $31.65
** IONS ups 2025 sales forecast to $725 mln to $750 mln, up from prior forecast of at least $600 mln; analysts were expecting 2025 sales to be $659.7 mln - LSEG
** IONS posts Q1 sales of $132 mln vs analysts' est of $125.3 mln - LSEG
** IONS reports Q1 loss of 93 cents, compared with a loss of 98 cents a year ago
** As of last close, stock down 14.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.